Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways
Rafael Barreto, Giorgia Mandili, Frank A. Witzmann, et al.
Frontiers in Physiology (2016) Vol. 7
Open Access | Times Cited: 166

Showing 26-50 of 166 citing articles:

Altered glucose metabolism and insulin resistance in cancer-induced cachexia: a sweet poison
Tamhida Masi, Bhoomika M. Patel
Pharmacological Reports (2020) Vol. 73, Iss. 1, pp. 17-30
Closed Access | Times Cited: 54
Chemotherapy-Induced Myopathy: The Dark Side of the Cachexia Sphere
Dean G. Campelj, Craig A. Goodman, Emma Rybalka
Cancers (2021) Vol. 13, Iss. 14, pp. 3615-3615
Open Access | Times Cited: 44
Skeletal muscle mitochondrial network dynamics in metabolic disorders and aging
Ciarán E. Fealy, Lotte Grevendonk, Joris Hoeks, et al.
Trends in Molecular Medicine (2021) Vol. 27, Iss. 11, pp. 1033-1044
Open Access | Times Cited: 43
The Mitochondria-Targeting Agent MitoQ Improves Muscle Atrophy, Weakness and Oxidative Metabolism in C26 Tumor-Bearing Mice
Fabrizio Pin, Joshua R. Huot, Andrea Bonetto
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 28
Chemotherapy-Induced Molecular Changes in Skeletal Muscle
Mafalda Barbosa Pedrosa, Samuel Barbosa, Rui Vitorino, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 905-905
Open Access | Times Cited: 18
The complex heterogeneity of immune cell signatures across wasting tissues with C26 and 5-fluorouracil-induced cachexia
Brandon N. VanderVeen, Thomas D. Cardaci, Brooke M. Bullard, et al.
AJP Cell Physiology (2024) Vol. 326, Iss. 2, pp. C606-C621
Closed Access | Times Cited: 6
ACVR2B/Fc counteracts chemotherapy-induced loss of muscle and bone mass
Rafael Barreto, Yukiko Kitase, Tsutomu Matsumoto, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 55
Platinum-induced muscle wasting in cancer chemotherapy: Mechanisms and potential targets for therapeutic intervention
Alexandra Moreira‐Pais, Rita Ferreira, Rui M. Gil da Costa
Life Sciences (2018) Vol. 208, pp. 1-9
Closed Access | Times Cited: 53
Proteomic profiling of skeletal and cardiac muscle in cancer cachexia: alterations in sarcomeric and mitochondrial protein expression
Angie M. Y. Shum, Anne Poljak, Nicholas L. Bentley, et al.
Oncotarget (2018) Vol. 9, Iss. 31, pp. 22001-22022
Open Access | Times Cited: 47
Development and progression of cancer cachexia: Perspectives from bench to bedside
Seongkyun Lim, Jacob L. Brown, Tyrone A. Washington, et al.
Sports Medicine and Health Science (2020) Vol. 2, Iss. 4, pp. 177-185
Open Access | Times Cited: 47
Bisphosphonate Treatment Ameliorates Chemotherapy-Induced Bone and Muscle Abnormalities in Young Mice
Alyson L. Essex, Fabrizio Pin, Joshua R. Huot, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 46
Factors influencing the efficacy of nutritional interventions on muscle mass in older adults: a systematic review and meta-analysis
Aitana Martin-Cantero, Esmee M. Reijnierse, Benjamin M. T. Gill, et al.
Nutrition Reviews (2020) Vol. 79, Iss. 3, pp. 315-330
Open Access | Times Cited: 45
The Impact of Immune Cells on the Skeletal Muscle Microenvironment During Cancer Cachexia
Brandon N. VanderVeen, E. Angela Murphy, James A. Carson
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 42
Mitochondrial Dysfunction in Cancer Cachexia: Impact on Muscle Health and Regeneration
Marc Beltrà, Fabrizio Pin, Riccardo Ballarò, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 3150-3150
Open Access | Times Cited: 40
Radiomics predicts risk of cachexia in advanced NSCLC patients treated with immune checkpoint inhibitors
Wei Mu, Evangelia Katsoulakis, Christopher J. Whelan, et al.
British Journal of Cancer (2021) Vol. 125, Iss. 2, pp. 229-239
Open Access | Times Cited: 34
Implications of mitochondrial fusion and fission in skeletal muscle mass and health
Vanina Romanello, Marco Sandri
Seminars in Cell and Developmental Biology (2022) Vol. 143, pp. 46-53
Closed Access | Times Cited: 22
Senotherapeutic drug treatment ameliorates chemotherapy-induced cachexia
Davis A. Englund, Alyssa M. Jolliffe, Gabriel J. Hanson, et al.
JCI Insight (2023) Vol. 9, Iss. 2
Open Access | Times Cited: 14
Maintenance of the branched-chain amino acid transporter LAT1 counteracts myotube atrophy following chemotherapy
Stephen Mora, Olasunkanmi A. J. Adegoke
AJP Cell Physiology (2024) Vol. 326, Iss. 3, pp. C866-C879
Closed Access | Times Cited: 5
Cancer cachexia: multilevel metabolic dysfunction
Mauricio Berriel Díaz, Maria Rohm, Stephan Herzig
Nature Metabolism (2024)
Closed Access | Times Cited: 5
Exogenous Gene Transmission of Isocitrate Dehydrogenase 2 Mimics Ischemic Preconditioning Protection
Alexander L. Kolb, Peter R. Corridon, Shijun Zhang, et al.
Journal of the American Society of Nephrology (2018) Vol. 29, Iss. 4, pp. 1154-1164
Open Access | Times Cited: 42
The effects of chemotherapy on energy metabolic aspects in cancer patients: A systematic review
Timia Van Soom, Samera El Bakkali, Nick Gebruers, et al.
Clinical Nutrition (2019) Vol. 39, Iss. 6, pp. 1863-1877
Closed Access | Times Cited: 42
Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia
Giuseppe Sirago, Elena Conte, Flavio Fracasso, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 40
HCT116 colorectal liver metastases exacerbate muscle wasting in a mouse model for the study of colorectal cancer cachexia
Joshua R. Huot, Leah J. Novinger, Fabrizio Pin, et al.
Disease Models & Mechanisms (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 35
ACVR2B antagonism as a countermeasure to multi‐organ perturbations in metastatic colorectal cancer cachexia
Joshua R. Huot, Fabrizio Pin, Ashok Narasimhan, et al.
Journal of Cachexia Sarcopenia and Muscle (2020) Vol. 11, Iss. 6, pp. 1779-1798
Open Access | Times Cited: 33
Role of myokines and osteokines in cancer cachexia
Fabrizio Pin, Lynda F. Bonewald, Andrea Bonetto
Experimental Biology and Medicine (2021) Vol. 246, Iss. 19, pp. 2118-2127
Open Access | Times Cited: 28

Scroll to top